Table 1.
Reports' characteristics
| n (%) n = 132 |
|
|---|---|
| Journal | |
| General medical journal | 20 (15.2) |
| Circulation | 15 (11.4) |
| American Heart Journal | 14 (10.6) |
| Catheter and Cardiovascular Intervention | 18 (13.6) |
| Journal of the American College of Cardiology | 17 (12.9) |
| American Journal of Cardiology | 15 (11.4) |
| Other | 33 (25.0) |
| Funding | |
| Public funding | 16 (12.1) |
| Manufacturer funding | 49(37.1) |
| Both public and manufacturer funding | 7 (5.3) |
| No funding | 3 (2.3) |
| Not reported | 57 (43.2) |
| Interventions | |
| BMS | 41 (31.1) |
| Polymer-coated stent | 19 (14.4) |
| DES | 64 (48.5) |
| Strategy of stent implantation | 8 (6.1) |
| Comparisons (experimental intervention vs control arm) | |
| DES vs BMS | 35 (26.5) |
| DES vs another DES | 19 (14.4) |
| DES vs same DES but with a different dosage | 5 (3.8) |
| DES vs balloon angioplasty | 6 (4.5) |
| DES vs polymer-coated stent | 3 (2.3) |
| DES vs surgery | 1 (0.8) |
| Polymer-coated stent vs BMS | 13 (9.8) |
| Polymer-coated stent vs angioplasty | 3 (2.3) |
| BMS vs another BMS | 13 (9.8) |
| BMS vs angioplasty | 10 (7.6) |
| BMS vs surgery | 9 (6.8) |
| BMS vs a strategy of stent implantation | 6 (6.8) |
| Strategy of stent implantation vs another strategy of stent implantation | 4 (3.0) |
| Strategy of stent implantation vs angioplasty | 5 (3.8) |
BMS = bare-metal stent
DES = drug-eluting stent